
PureTech Health plc — Investor Relations & Filings
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data | 2026-06-09 | English | |
| Holding(s) in Company | 2026-06-04 | English | |
| Holding(s) in Company | 2026-05-29 | English | |
| Holding(s) in Company | 2026-05-27 | English | |
| Holding(s) in Company | 2026-05-22 | English | |
| Correction - Holding(s) in Company | 2026-05-15 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 48008391 | PRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data | 2026-06-09 | English | ||
| 47969531 | Holding(s) in Company | 2026-06-04 | English | ||
| 47891182 | Holding(s) in Company | 2026-05-29 | English | ||
| 47777829 | Holding(s) in Company | 2026-05-27 | English | ||
| 46846084 | Holding(s) in Company | 2026-05-22 | English | ||
| 46349644 | Correction - Holding(s) in Company | 2026-05-15 | English | ||
| 45566389 | PRTC To Showcase Deupirfenidone at ATS Conference | 2026-05-13 | English | ||
| 44107110 | Holding(s) in Company | 2026-05-08 | English | ||
| 43307615 | Holding(s) in Company | 2026-05-07 | English | ||
| 39399460 | PureTech's Seaport Prices Upsized IPO Nasdaq: SPTX | 2026-05-01 | English | ||
| 38655488 | Notice of Meeting for 2026 AGM | 2026-04-29 | English | ||
| 38642553 | Proxy Form for 2026 AGM | 2026-04-29 | English | ||
| 38637441 | 20-F - PureTech Health plc (0001782999) (Filer) | 2026-04-29 | English | ||
| 38625474 | Annual Report and Accounts 2025 | 2026-04-29 | English | ||
| 38625445 | Annual Report and Accounts 2025 | 2026-04-29 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for PureTech Health plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Daesung Microbiological Labs. Co. Ltd
Develops, manufactures, and distributes animal pharmaceutic…
|
036480 | KR | Manufacturing |
|
DAEWON PHARMACEUTICAL CO.,LTD
Develops and manufactures prescription drugs and finished p…
|
003220 | KR | Manufacturing |
|
DAEWOONG CO.,LTD
A holding company in the biotech and healthcare sectors dev…
|
003090 | KR | Manufacturing |
|
DAEWOONG PHARMA
Develops and manufactures drugs, biologics, and active phar…
|
069620 | KR | Manufacturing |
|
DAIICHI SANKYO COMPANY, LIMITED
A global healthcare company that researches and develops no…
|
4568 | JP | Manufacturing |
|
Daito Pharmaceutical Co., Ltd.
Integrated manufacturer of APIs and finished drugs for gene…
|
4577 | JP | Manufacturing |
|
Dare Bioscience, Inc.
A clinical-stage biopharmaceutical company advancing innova…
|
DARE | US | Manufacturing |
|
Darya-Varia Laboratoria Tbk
A pharmaceutical company manufacturing, trading, and distri…
|
DVLA | ID | Manufacturing |
|
Dawnrays Pharmaceutical (Holdings) Limited
Develops, manufactures, and sells non-patented cephalospori…
|
2348 | HK | Manufacturing |
|
Day One Biopharmaceuticals, Inc.
Commercial-stage company developing targeted cancer therapi…
|
DAWN | US | Manufacturing |
PureTech Health plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4932/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4932 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4932 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4932 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4932}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PureTech Health plc (id: 4932)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.